؉ -ATPases (V-ATPases), a family of multimeric proton pumps, are involved in a wide variety of physiological processes. We have identified two mouse genes, Atp6g1 and Atp6g2, encoding the G1 and G2 isoforms of the V-ATPase G subunit, respectively. G1 was distributed ubiquitously in the tissues examined, whereas G2 was specifically distributed in central nervous system neurons. G1 was expressed at an early embryonic stage, whereas G2 transcription was significantly induced at 10.5 days postcoitus (embryonic day 10.5, i.e. 2 days before axon outgrowth). Both G1 and G2 were strongly expressed in cortical and hippocampal neurons, cerebellar granule cells, and Purkinje cells. Immunohistochemistry with isoform-specific antibodies revealed that G2 was localized in cell bodies, dendrites, and axons. In addition, electron microscopy and subcellular fractionation indicated that G2 was localized in synaptic vesicles, whereas G1 was not detectable. G1 and G2 exhibit 62% identity, and both isoforms were immunoprecipitated with the c and A subunits of VATPase. G2 could complement the yeast deletion mutant ⌬vma10, which lacks the G subunit. The V-ATPases containing the G1 and G2 isoforms, respectively, showed similar K m(ATP) values and maximal velocity. These results indicate that G1 and G2 are bona fide subunits of V-ATPases and that the enzyme with the G2 isoform is involved in synaptic vesicle acidification.
The vacuolar H ϩ -ATPases (V-ATPases), 1 which are ATP-dependent proton pumps, are ubiquitous enzymes that translocate H ϩ across the membranes of endomembrane organelles, including vacuoles, lysosomes, endosomes, the Golgi apparatus, chromaffin granules, and coated vesicles (1) (2) (3) . The same type of enzyme is also found in the plasma membranes of specialized cells such as osteoclasts and renal epithelial cells (4, 5) . Thus, V-ATPases could be localized in different organelles and membranes, leading to their specific functions.
In neurons, the pH gradient (pH ϳ5.2 inside) (6, 7) and membrane potential generated by V-ATPase drive the neurotransmitter accumulation in synaptic vesicles (8, 9) . The neurotransmitters are released from nerve terminals upon regulated exocytosis of the vesicles (8 -11) . V-ATPase activity is also essential for intracellular membrane trafficking, processing or degradation of proteins, and receptor-mediated endocytosis in other organelles of neuronal cells.
V-ATPases (V 1 V 0 ) have a structure and mechanism similar to those of F-type ATPases (ATP synthases, F 1 F 0 ), and their ATP-dependent conformational changes are transmitted from the membrane extrinsic sector (V 1 or F 1 ) to the proton pore (V 0 or F 0 ) through a number of subunits forming a stalk (1) (2) (3) . Studies on knockout mice lacking the V 0 c subunit, encoded by a single gene (12, 13) , have indicated that V-ATPases are essential for early development (14, 15) .
The diverse functions of V-ATPases may be due to the utilization of a specific subunit isoform(s). Consistent with this notion, multiple subunit isoforms have been found for the largest subunit, a, of the V 0 sector in nematode (16) , chicken (17) , mouse (18 -21) , cow (22) , and man (23) . a4 is specifically expressed in renal intercalated cells (20, 21, 23) , and mutations of it cause renal acidosis (23) , whereas other isoforms (a1, a2, and a3) are expressed ubiquitously in the tissues examined (17) (18) (19) . Isoform a3 is a component of osteoclast plasma membrane enzyme (18) , and its defect results in osteopetrosis (24) . In the case of the mammalian V 1 sector, the expression of B1 is strictly limited to kidney and cochlea (25) , whereas B2 is expressed ubiquitously. We have recently identified two isoforms (E1 and E2) of the mouse E subunit (26) . In contrast to the ubiquitously distributed E2 subunit, E1 is expressed specifically in testis and is required for acrosome acidification. Thus, V-ATPases may have two kinds of isoforms: those expressed in specific cells (a4, B1, and E1) and those that show specific localization after cellular differentiation (a3).
The bovine G subunit was shown to contain two kinds of isoforms, although the expression pattern and localization of each isoform were not shown (27) . In this study, we have characterized two mouse genes, Atp6g1 and Atp6g2, encoding the G1 and G2 isoforms of the V-ATPase G subunit, respectively. G2 was found exclusively in central nervous system neurons and exhibits high similarity to G1, which is expressed ubiquitously. In addition to the cell bodies and dendrites, we found that V-ATPases of the G2 isoform were localized in synaptic vesicles in axons, whereas those of the G1 isoform were not detectable. Our results constitute the first evidence that a unique V-ATPase with the G2 isoform is involved in the acidification of synaptic vesicles in central nervous system neurons.
EXPERIMENTAL PROCEDURES
Cloning of cDNAs Coding for Mouse G1 and G2 Isoforms-The GenBank TM /EBI Data Bank of expressed sequence tags (ESTs) was searched using the yeast Vma10p sequences (28) . The mouse EST clone containing the entire open reading frame for the G1 or G2 isoform was verified by ABI Prism ® BigDye TM terminator cycle sequencing (Applied Biosystems, Inc.).
In Situ Hybridization-Digoxigenin-11-UTP-labeled single-stranded RNA probes were prepared with a digoxin/RNA labeling mixture and the corresponding T3 or T7 RNA polymerase (Roche Molecular Biochemicals) according to the manufacturer's instructions. The 498-and 932-bp fragments derived from the 3Ј-untranslated regions of G1 and G2, respectively, were cloned into the pBluescript II vector (Stratagene) and used to prepare probes. In situ hybridization was performed using 8-m cryosections of the brains of ICR mice (ϳ8 -10 weeks old) as previously described (29) . Sections were hybridized with probes at 45°C for 16 h and then washed successively. For the reaction with antidigoxigenin antibodies, slides were washed with buffer A (100 mM Tris-HCl and 150 mM NaCl, pH 7.5). Samples were treated with 0.5% blocking reagent (Roche Molecular Biochemicals) in buffer A and then incubated with alkaline phosphatase-coupled anti-digoxigenin antibodies (Roche Molecular Biochemicals) diluted 1:750 in buffer A for 1 h. The slides were washed with buffer A and then incubated in buffer B (100 mM Tris-HCl and 50 mM MgCl 2 , pH 9.5). Alkaline phosphatase activity was abolished with Tris/EDTA, and the slides were rinsed in water, counterstained with methyl green, and then mounted with Crystal Mount (Biomeda). Whole-mount in situ hybridization was performed as previously described (30) .
Complementation of Yeast ⌬vma10 with G1 or G2-The entire open reading frames for G1 and G2 were amplified by PCR with HiFi TM polymerase (Roche Molecular Biochemicals) and cloned into the pKT10 or pKT10-N-Myc vector (31) . The resulting plasmids, pKT-G1 (or pKT-N-Myc-G1) and pKT-G2 (or pKT-N-Myc-G2), were transformed into ⌬vma10 (MAT␣ ⌬vma10::LEU2 ura3-52 leu2-3,112 his4-519 ade6 pep4-3). ⌬vma10 was generated following the method described previously (32) , and gene disruption was confirmed by Southern analysis. The transformants were streaked onto YPD (yeast/peptone/dextrose) plates buffered to either pH 5.0 or 7.5 (33) .
Antibodies against V-ATPase Subunits-Polyclonal antibodies against G1 or G2 were raised in rabbits by immunization with peptides corresponding to each isoform (G1, KETREKMTVLQNYFEQNRDE, positions 75-94; G2, QATRRQVQGMQSSQQRNRER, positions 75-94). The antisera were purified on affinity columns with coupled bacterially expressed recombinant proteins. The anti-A subunit antiserum was from Wako Bioproducts. The anti-c subunit antiserum was kindly provided by Dr. S. Ohkuma (34) .
Purification of Synaptic Vesicles from Brain and Lysosomal Membranes from Liver-Synaptic vesicles were prepared from mouse brains at 4°C as described by Huttner et al. (35) . Briefly, whole mouse brains were homogenized in buffered sucrose (320 mM sucrose and 4 mM HEPES-NaOH, pH 7.4); the homogenate was centrifuged at 800 ϫ g for 10 min; and the supernatant (S1) was centrifuged for 15 min at 9200 ϫ g. The resulting supernatant (S2) was centrifuged at 100,000 ϫ g for 1 h, yielding S3 and P3 (supernatant and pellet, respectively). The 9200 ϫ g pellet (P2) was resuspended in the buffered sucrose and centrifuged at 10,200 ϫ g for 15 min. The resulting pellet (P2Ј) was resuspended in the same buffer and homogenized with 9 volumes of ice-cold water. The mixture was added to 1 M HEPES-NaOH, pH 7.4, to a final concentration of 7.5 mM; incubated on ice for 30 min; and centrifuged at 25,000 ϫ g for 20 min, yielding the LP1 pellet and LS1 supernatant fraction. LS1 was further centrifuged at 165,000 ϫ g for 2 h, and LP2 was suspended in 40 mM sucrose. LP2 was applied to a continuous sucrose gradient (50 -800 mM) and centrifuged at 65,000 ϫ g for 5 h. Fractions containing synaptophysin (a synaptic vesicle protein marker) were used as synaptic vesicle fractions.
The lysosomal membranes were prepared using OptiPrep (Nycomed Pharma) as described previously (36) . The fractions containing the lysosomal membrane marker LAMP-2 (37) were used for measuring ATPase activity.
Measurement of ATPase Activity-ATPase activity was measured using a coupled spectrophotometric assay (26) with minor modifications. For determining the K m(ATP) and V max for V-ATPase, concanamycin-sensitive ATPase activity was measured over a range of ATP concentrations between 0.05 and 2.0 mM. Synaptic vesicles (8 g of protein) or lysosomal membranes (30 g of protein) were incubated in assay buffer (5 mM HEPES-NaOH, pH 7.0, 4 mM KCl, 0.3 M sucrose, 5 mM MgCl 2 , 1.5 mM phosphoenolpyruvate, 0.2 mM NADH, 20 units/ml pyruvate kinase, and 10 units/ml lactate dehydrogenase) with 0.1% dimethyl sulfoxide or 1 M concanamycin A (in the same solvent) at 37°C for 2 min. The assay was started by adding various concentrations of ATP, and the absorbance at 340 nm was continuously monitored using a Hitachi UV-2500 PC spectrophotometer.
Solubilization of V-ATPase and Assay of Immunopurified ATPase Activity-For solubilization of V-ATPase, the brain membrane fraction (5 mg/ml) was incubated at 4°C for 10 min in 20 mM Tris-HCl, pH 7.0, containing 1 mM EDTA, 2% n-octyl ␤-glucopyranoside, 1 mM dithiothreitol, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, and complete protease inhibitor mixture (Roche Molecular Biochemicals), and then centrifuged at 100,000 ϫ g for 30 min. ATPase activity bound to protein A-Sepharose beads was assayed as follows. Anti-G1 or anti-G2 IgG antibody (100 g) was incubated in 20 l of 25 mM Tris-HCl, pH 7.0, containing 136 mM NaCl, 2.7 mM KCl, and a 25% suspension of protein A beads at room temperature for 2 h. Beads were washed twice and resuspended in the same buffer (original volume). The antibody-bound beads were then incubated with solubilized membranes at 4°C for 1.5 h, rinsed extensively, and resuspended in 20 l of the same buffer. The ATPase activities were assayed immediately in buffer containing 50 mM Tris-HCl, pH 7.0, 150 mM KCl, 6 mM MgCl 2 , and 100 g/ml phosphatidylglycerol with or without concanamycin A using [␥-
32 P]ATP (0.1-5 mM) (38) . The amount of membrane protein bound to the beads was estimated as described previously (39) .
Hippocampal and Cerebellar Primary Cultures-Primary cultures of hippocampal and cerebellar cells were carried out using 18.5-day postcoitus embryonic mouse brains (40) . In brief, cells were dissociated by gentle homogenization with a fire-polished Pasteur pipette and then plated onto poly-D-lysine-coated culture slides. They were cultured in Neurobasal TM medium (Invitrogen) containing B-27 supplement (Invitrogen), 500 M L-glutamine, 25 M L-glutamic acid, and 25 M ␤-mercaptoethanol for the first 4 days and maintained by replacing the medium every 4 days.
Immunohistochemistry and Fluorescence Microscopy-Whole brains were obtained from adult ICR mice, cryosectioned at 12 m, fixed with 4% paraformaldehyde, and then subjected to immunohistochemistry (20) . Hippocampal and cerebellar cells cultured for 14 days were fixed with 4% paraformaldehyde and then washed with 0.1 M glycine in phosphate-buffered saline. After blocking with phosphate-buffered saline containing 0.4% saponin, 2% normal goat serum, and 1% bovine serum albumin, cells were labeled with primary and secondary antibodies. After extensive washing with the same buffer, the cells were mounted onto slides with Vectashield (Vector Labs Inc.) and then visualized using a laser scanning confocal imaging system (LSM510, Carl Zeiss, Inc.). The primary antibodies used were anti-microtubule-associated protein-2 (MAP2) (Sigma), anti-2Ј,3Ј-cyclic nucleotide 3Ј-phosphodiesterase (Sigma), anti-glial fibrillary acidic protein (Transduction Laboratories), and anti-synaptophysin (Progen). The secondary antibodies used were fluorescein isothiocyanate-conjugated goat antimouse IgG antibodies and Cy3-conjugated goat anti-rabbit IgG antibodies (both from (Jackson ImmunoResearch Laboratories, Inc.). The cells were counterstained with TOPRO-3 (diluted 1:500; Molecular Probes, Inc.) to identify nuclei.
Cell Fractionation and Immunoprecipitation of V-ATPase-All operations were carried out at 4°C. Adult mouse tissues were dissected and suspended in ice-cold 10 mM HEPES-NaOH, pH 7.4, containing 0.25 M sucrose, 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and complete protease inhibitor mixture and then homogenized in a Wheaton homogenizer. The lysates, obtained upon centrifugation at 1000 ϫ g for 5 min, were centrifuged at 8000 ϫ g for 10 min. The supernatants were further centrifuged at 100,000 ϫ g for 60 min. The pellets suspended in phosphate-buffered saline containing 1 mM EDTA and 10% glycerol were used as membrane fractions. Western blotting was carried out as previously described (18) . For immunoprecipitation of V-ATPase, the supernatant (solubilized V-ATPase) was incubated with 1 g of anti-G1 or anti-G2 antibody or preimmune IgG for 1 h and then with protein A-Sepharose beads for 1 h. After washing the beads six times with the above buffer, the immunoprecipitates were boiled in sample buffer (41) and subjected to Western blotting.
Electron Microscopy-The pre-embedded silver enhancement immunogold method was used (26) . After perfusion with 4% paraformaldehyde and 0.2% picric acid in phosphate-buffered saline, the mouse brain was dissected and fixed in the same solution at 4°C for 2 h. Cryosec-tions (6 m) were reacted with primary antibodies overnight, followed by incubation with colloid gold (1.4-nm diameter)-conjugated secondary antibodies. The gold labeling was intensified using a silver enhancement kit (Nano Probes). (42) . The mouse EST clones fall into two categories, both of which are homologous to Vma10p, indicating the presence of two genes. We have determined the sequences of two EST clones (DDBJ/GenBank TM /EBI accession numbers BG175176 and BG296113) and named the proteins encoded by them the G1 and G2 isoforms, respectively.
RESULTS

Identification of Mouse G Isoforms-Similarity
Both isoforms comprise 118 amino acid residues and show high homology (76% similarity) to yeast Vma10p (Fig. 1) . G1 and G2 exhibit 62% identity to each other. The amino-terminal regions of G1 and G2 are highly conserved, whereas their carboxyl-terminal regions are variable (Fig. 1) . The mouse genes encoding G1 and G2 were designated as Atp6g1 and Atp6g2, respectively. They were mapped to chromosomes 4 and 17, respectively, according to the RIKEN Database. 2 The GenBank TM /EBI accession numbers for the cDNAs (Atp6g1 and Atp6g2) are AB076406 and AB076405, respectively.
Expression of Isoforms in Developing and Adult Central Nervous System Neurons-The 1.2-kb G1 transcript was detected in all tissues examined, whereas the 1.6-kb G2 transcript was expressed predominantly in brain ( Fig. 2A) . Consistent with its ubiquitous expression, G1 was detected from an early embryonic stage (4.5 days postcoitus). On the other hand, G2 was induced at 10.5 days postcoitus and was maintained at all subsequent stages (Fig. 2B) . 10.5 days postcoitus is the stage when the first motor neurons are established, with the outgrowth of axons starting 2 days later (43) .
Upon whole-mount in situ hybridization of 10.5-day postcoitus embryos, G1 mRNA was detected in all tissues (Fig. 3A) , whereas G2 was exclusively expressed in the central nervous system (Fig. 3B, arrowheads) . Both isoforms were highly expressed in similar regions of the adult brain (Fig. 3C ). They were strongly expressed in the cerebral cortex; dentate gyrus; the pyramidal neurons in the Ammon's fields of the hippocampus; and Purkinje cells in the cerebellum.
Specific Antibodies for G1 and G2-The antibodies raised against G1 or G2 using specific peptides (Fig. 1) recognized the corresponding isoform expressed in yeast (Fig. 4A) . Immunoblotting with anti-G2 IgG antibody revealed an 18-kDa protein only in brain, whereas the anti-G1 antibody recognized a 16-kDa band in all tissues (brain and kidney are shown in Fig. 4A ). The molecular sizes of both bands appeared to be slightly larger than those predicted from the corresponding cDNAs (13.7 and 13.6 kDa, respectively), possibly due to their amino-terminal regions being rich in lysine and arginine.
G1 and G2 Are Functional V-ATPase Subunits-Membranes were obtained from brains and treated with octyl glucoside. The solubilized V-ATPase fraction was incubated with anti-G1 or anti-G2 IgG antibody, and the immunoprecipitate was subjected to PAGE. The precipitate contained the A and c subunits of the V 1 and V 0 sectors, respectively, suggesting that both G1 and G2 are functional subunits of V-ATPase (Fig. 4B) .
We have also examined whether or not the mouse isoforms can complement the yeast ⌬vma10 mutant lacking the G subunit. The open reading frame of G1 or G2 was placed under the control of the yeast TDH3 constitutive promoter, and the resulting plasmid expressing the native G1 or G2 subunit with or without a Myc tag was introduced into ⌬vma10 cells. The mutant cells could not grow in neutral pH medium (Fig. 5,   2 Available at gsc.riken.go.jp/e/FANTOM/map/mouse/.
FIG. 1. Alignment of the amino acid sequences of G subunit isoforms.
The sequences of mouse G subunit isoforms and yeast Vma10p were aligned to obtain maximal homology. Identical residues are indicated by gray boxes, and the regions used for antibody preparation are underlined.
FIG. 2. Northern blot analysis of G1 and G2 transcripts in mouse tissues. Mouse multiple-tissue Northern blots (CLONTECH; 2 g of poly(A)
ϩ RNA/lane) (A) and embryonic stage Northern blots (Seegene) (B) were hybridized with the 32 P-labeled G1 or G2 probe. The positions of the G1 (1.2 kb) and G2 (1.6 kb) transcripts are indicated (arrows). SK, skeletal; dpc, days postcoitus.
Vector), whereas those with VMA10 or mouse G2 (without a tag) could (Fig. 5, VMA10 and G2 ). This indicated that expression of mouse G2 functionally complemented ⌬vma10. Similar complementation was not observed with G1 (Fig. 5, G1) .
Localization of G1 and G2 in Brain-The brain-specific expression of G2 suggests that a V-ATPase of this isoform may be involved in neuron-specific function(s). Because both G1 and G2 are highly expressed in the adult brain, we suspected that the intracellular localizations of the two isoforms may be different. As expected, immunostaining with isoform-specific antibodies revealed that the intracellular localizations of G1 and G2 were remarkably distinct (Fig. 6) . Strong signals for G1 were detected in the cell bodies of hippocampal neurons, Purkinje cells, and cerebral neurons, whereas ones for G2 were detected in fibers in the axonal region (Fig. 6, arrowheads) , in addition to cell bodies and dendrites (Fig. 6) .
We have labeled G1 or G2 in cultured hippocampal or cerebellar cells together with brain MAP2 (44), glial fibrillary acidic protein (45) , and 2Ј,3Ј-cyclic nucleotide 3Ј-phosphodiesterase (46) , markers of neurons, astrocytes, and oligodendrocytes, respectively. G1 was positive in the three cell types (Fig. 7, A-C) , whereas G2 was expressed only in MAP2-positive cells (Fig.  7C) . These results indicated that G2 was expressed exclusively in neuronal cells. On the other hand, the ubiquitously distributed G1 subunit was expressed in astrocytes and oligodendrocytes, in addition to neurons.
G2 was clearly found in the axonal domain in addition to dendrites and cell bodies (Fig. 7C) . Furthermore, G2 staining coincided with staining of synaptophysin (Fig. 8) , a protein marker of synaptic vesicles (47) . In contrast, G1 was expressed in cell bodies and somatodendritic compartments, but no specific staining was detected in the axonal regions (Fig. 7C,  arrowheads) . We have also examined the localization of G1 and G2 in axonal regions using immunoelectron microscopy. G2 was detected in presynaptic vesicles (Fig. 8D, arrows) , whereas no G1 was found in these regions (Fig. 8E) . The subcellular distribution of the G2 subunit was similar to that of the A or c subunit of V-ATPase during brain fractionation, and these subunits were enriched in the synaptic vesicle preparation (Fig. 9A, SV) . In contrast, G1 was not detectable in synaptosomal fractions and purified synaptic vesicles, although it could be detected in other fractions with V-ATPase subunits. Taken together, these results suggest that synaptic vesicles contain a unique V-ATPase with the G2 isoform, but not ubiquitous G1 subunit. The G2 isoform and the A subunit were also found in the soluble fraction (LS2), which contained a significantly reduced amount of synaptophysin and the c subunit (Fig. 9A) . This result is consistent with previous findings (48, 49) , suggesting a dynamic association-dissociation between the cytosolic and transmembrane portions of the V-ATPase.
Enzymatic Properties of V-ATPase with the G1 or G2 Isoform-It was of interest to compare the enzymatic properties of shown (B, arrowheads) . Sections of adult brains were also hybridized with the G1 or G2 probe (C). The cortical, cerebellar, and hippocampal regions are shown. ML, molecular layer; P, Purkinje cells; GL, granular layer; CA, Cornu Ammon; DG, dentate gyrus. Scale bars ϭ 400 m (A and B) and 50 m (C).
FIG. 4. Western blot analysis of G1 and G2 expression and association of the isoforms with other V-ATPase subunits.
A, total lysates of murine brain and kidney together with ones of yeast expressing the G1-Myc or G2-Myc fusion protein were subjected to gel electrophoresis in the presence of SDS. The results from immunoblotting with the purified IgG against each isoform are shown. B, the octyl glucoside-solubilized fraction (0.45 mg of protein) was incubated with anti-G1 (␣-G1) or anti-G2 (␣-G2) antibody or control IgG in the buffer used for the solubilization of V-ATPase. Immunoprecipitates (IP) were subjected to gel electrophoresis, blotted onto nitrocellulose sheets, and incubated with antibody against the A or c subunit. The positions of the A and c subunits are indicated by arrows. As a control, the brain membrane fraction was also subjected to electrophoresis (membrane).
the pumps containing the G1 and G2 isoforms, respectively. We measured the K m(ATP) and V max for concanamycin A-sensitive ATP hydrolysis using the purified synaptic vesicles containing V-ATPase with G2 and lysosomal membranes containing only G1 (Fig. 9B, fr. 17 ). The K m(ATP) was 252 M for synaptic vesicles (G2) and 250 M for lysosomal membranes (G1) ( Table  I ), indicating that the G1-and G2-containing enzymes have no kinetic difference. It was also of interest to determine whether the kinetic property of V-ATPase with G1 or G2 was retained with the purified enzyme. The anti-G1 or G2 antibody (added at a 1:1 protein ratio of antibodies to vesicles) had no effect on ATP-dependent proton transport in synaptic vesicles or lysosomal vesicles, indicating that the antibodies could be used for immunoaffinity purification. The V-ATPase with G1 or G2 bound to the affinity beads retained concanamycin A-sensitive ATPase activity. The K m(ATP) value for G1 or G2 was comparable to that observed with the enzyme in the organellar membranes (Table I) .
DISCUSSION
Essential steps for neural chemical transmission include the accumulation of neurotransmitters in synaptic vesicles and their release through regulated exocytosis. For the concentration of neurotransmitters, specific vesicular transporters couple with the electrochemical proton gradient generated by VATPase (6, 7, 9 -11). Thus, V-ATPases play key physiological roles in the nervous system. One important question to be answered is how the V-ATPases localized in synaptic vesicles reach the axon terminals. There is evidence suggesting that synaptic vesicles are assembled at the axon terminals and that sults suggest that the V 1 and V 0 domains are transported separately in axons. It is also of interest to know whether neurons or synaptic vesicles have a unique V-ATPase.
We have identified two isoforms (G1 and G2) of the mouse V 1 G subunit. Immunoprecipitation demonstrated that both isoforms were associated with other V-ATPase subunits. In addition, the G2 (but not the G1) isoform functionally complemented the yeast counterpart VMA10 null mutation, indicating that mouse G2 can assemble with other V-ATPase subunits to form a functional enzyme complex. On the other hand, yeast V-ATPase with mouse G1 was not functional. The defect of the enzyme may be due to the weakly conserved carboxyl-terminal region, which may be required for the assembly of the G subunit with V-ATPase.
Interestingly, G2 was expressed specifically in brain and was localized exclusively in neurons. Immunofluorescence microscopy, immunoelectron microscopy, and subcellular fractionation revealed that a V-ATPase with G2 was localized in synaptic vesicles. In contrast, ubiquitous G1 was localized mainly in cell bodies and the proximal portions of dendrites, but was not detectable in axons, as shown by immunofluorescence microscopy and confirmed with immunogold staining by electron microscopy. It is possible that the V-ATPases with G1 and G2 may differ in their activities. However, we found that the synaptic vesicle V-ATPase with G2 and the lysosomal membrane V-ATPase with G1 showed similar kinetic properties. Essentially the same kinetic results were obtained with immunopurified V-ATPase (G1 or G2). Thus, it became of interest to examine whether the G subunit isoforms are involved in the transport of V-ATPases to specific destinations because only those with G2 were targeted to the synaptic vesicles.
Two bovine G isoforms have been purified previously (27) . They showed differential expressions in tissues: G1, brain, kidney, heart, and spleen; and G2, brain. Recombinant bovine G1 and G2 exhibited different Ca 2ϩ -and Mg 2ϩ -activated ATPase activities when reconstituted with the A, B, C, and E subunits (27) . However, the two isoforms were isolated by different procedures, suggesting that their observation could not due to the intrinsic properties of V-ATPase with G1 or G2 because purification procedures for recombinant isoforms may B, preparation of lysosomes with V-ATPase containing the G1 isoform. Lysosomal membranes were prepared by OptiPrep density gradient centrifugation (10 -35% iodixanol; total volume of 12.5 ml) and fractionated into 25 tubes (0.5 ml/tube, numbered from the bottom). Fractions (10 l; fr.) were subjected to gel electrophoresis, followed by Western blotting with antibodies against LAMP-2 and the G1, G2, A, and c subunits. The asterisk indicates the fraction used in the measurement of ATPase activity (Table I) . a ATPase activities were measured in purified synaptic vesicles containing G2 (8 g of membrane protein) or in liver lysosomal membranes containing G1 (30 g of membrane protein), or immunopurified enzyme (0.1 g). Activities were measured with or without 1 M concanamycin A, and the results shown represent the concanamycin A-sensitive fraction of the activity. K m and V max were calculated from Lineweaver-Burk plots of the reciprocal of the initial ATP concentration versus the reciprocal of the initial rate of ATPase activity (nmol/min/mg). affect reconstitution. In this regard, we found that the VATPases with G1 from lysosomal membranes and with G2 from synaptic vesicles, respectively, showed similar ATPase activities.
The human and mouse G2 isoforms were mapped adjacent to the major histocompatibility complex class III locus (52) . Many genes in the class III region of the human major histocompatibility complex encode proteins involved in immune and inflammatory responses. A role in the immune responses has been suggested for V-ATPase (53, 54) , and interleukin-1 has been shown to modulate its activity in a dose-dependent manner (53) . However, we did not detect G2 expression in macrophage cell lines (data not shown).
In summary, we have shown that V-ATPase with the G2 isoform is specifically localized in neural synaptic vesicles, whereas that with the G1 isoform is expressed ubiquitously. The G2 isoform may be involved not only in the acidification of synaptic vesicles, but also in the assembly of a functional proton pump to neuron-specific organelles.
